CDH3 and ovarian cancer: In this context, P-cadherin inhibition using RNAi leads to a decrease in cancer cell peritoneal attachment and in the number of metastatic ovarian cancer foci, suggesting that P-cadherin is involved in the early stages of metastatic cell adhesion [70].